Lv1
42 积分 2024-10-19 加入
Development and validation of a cuproptosis-related lncRNA signature for predicting prognosis and immunotherapy response in breast cancer: a retrospective analysis of TCGA data
9天前
已完结
Mining in Endometrial Cancer Based on the TCGA Database and Constructing Prognostic Models
13天前
已完结
Machine Learning-Based Prognostic Modeling of Seven Signatures Associated with Lysosomes for Predicting Prognosis and Immune Status in Clear Cell Renal Cell Carcinoma
13天前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
3个月前
已完结
Efficacy and safety of first-line maintenance therapy with lurbinectedin plus atezolizumab in extensive-stage small-cell lung cancer (IMforte): a randomised, multicentre, open-label, phase 3 trial
3个月前
已完结
Ifinatamab Deruxtecan in Patients With Extensive-Stage Small-Cell Lung Cancer: Primary Analysis of the Phase 2 IDeate-Lung01 Trial
5个月前
已完结
Emerging therapies targeting the delta-like ligand 3 (DLL3) in small cell lung cancer
5个月前
已完结
The PESGA Trial: A prospective, open-label, single-arm, phase II study to evaluate first line therapy for extensive-stage small cell lung cancer (ES-SCLC) patients, treated by induction carboplatin/etoposide/pembrolizumab followed by maintenance of pembrolizumab/ sacituzumab govitecan
5个月前
已完结
Redefining the Fight Against SCLC: Standards, Innovations, and New Horizons
5个月前
已完结
Cell-intrinsic PD-L1 signaling drives immunosuppression by myeloid-derived suppressor cells through IL-6/Jak/Stat3 in PD-L1-high lung cancer
8个月前
已完结
皖公网安备34019202002308
